SNCA and Parkinson disease: Glymphatic dysfunction is suggested to be implicated in the development of Parkinson’s disease (PD), which has a profile of α-synucleinopathy, wherein aggregated alpha-synuclein deposits cause neuropathology, and neuroimaging studies have contributed to our understanding of the pathophysiology and diagnosis of PD [49–52].